MEGHAN RAMSAY: Open Payments
NPI 1700946050 · VERO BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,935 in 130 payments from 35 companies in 2025. Trend: 2023 $0 · 2024 $1,145 · 2025 $2,935
Food & beverage: $2,681Education: $254
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $471 |
| Merck Sharp & Dohme LLC | 11 | $226 |
| PFIZER INC. | 15 | $200 |
| GlaxoSmithKline, LLC. | 10 | $183 |
| Novartis Pharmaceuticals Corporation | 8 | $164 |
| AstraZeneca Pharmaceuticals LP | 5 | $156 |
| Daiichi Sankyo Inc. | 5 | $148 |
| ARRAY BIOPHARMA INC | 7 | $141 |
| Eisai Inc. | 5 | $102 |
| Incyte Corporation | 4 | $94 |
Products named: ENHERTU, KEYTRUDA, RYBREVANT, TECVAYLI, XTANDI, KISQALI, ZEJULA, Lenvima.
Industry payments across FL — which companies pay providers there.
